Invitro International

Invitro International FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Invitro International (IVRO) as of Oct 11, 2026 is -7.12 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 92.40 % — a change of -107.70% (lower).

FCF Conversion

-7.12 %

YoY

-107.70%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Invitro International is 2025 -7.12 % . FCF Conversion Rate (FCF/EBITDA) of Invitro International was 2024 92.40 % . It decreases by -107.70% lower compared to the previous year.

The Invitro International FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2017
27.40 USD
Jan 1, 2019
190.49 USD
Jan 1, 2020
-51.06 USD
Jan 1, 2021
30.10 USD
Jan 1, 2022
146.87 USD
Jan 1, 2023
-3,860.98 USD
Jan 1, 2024
92.40 USD
Jan 1, 2025
-7.12 USD
The Invitro International FCF Conversion history
YEARFCF ConversionYoY
-7.12 %-107.70%
92.40 %-102.39%
-3,860.98 %-2,728.76%
146.87 %+388.00%
30.10 %-158.95%
-51.06 %-126.80%
190.49 %+595.17%
27.40 %-78.84%
129.50 %—
Access this data via the Eulerpool API

Invitro International Stock analysis

What does Invitro International do? Invitro International is a leading company in the development of cell and tissue cultures as well as test systems for the pharmaceutical, cosmetic, and biotechnology industry. The company was founded in 1982 by Dr. George K. J. Uehara, a renowned scientist and specialist in the field of cell culture technology. His aim was to create a reliable alternative to animal testing to meet the industry's need for safe and effective test systems. Invitro International offers a wide range of products, including cell cultures and tissue samples derived from human or animal tissue. These are of the highest quality and are manufactured under strict quality controls. The tissue cultures are obtained from living organs and are ideal for the development of new drugs and cosmetics, as well as for studying the effects of environmental toxins and chemicals. Another focus of Invitro International is the development of test systems tailored to the needs of customers. These can include in vitro tests on cell and tissue cultures, as well as molecular analysis and screening methods. The company is divided into various industries and sectors, including pharmaceutical research, toxicology, cosmetics industry, biotechnology, and environmental research. Each of these sectors is supervised by specialized scientists and experts who have in-depth knowledge and experience in their respective fields. Invitro International places great emphasis on environmentally friendly and ethical standards in the development of new test systems and products. The company is also involved in various initiatives to promote alternatives to animal testing and actively advocates for the protection and welfare of animals. One of Invitro International's most well-known products is the Eye Irritation Test System (EITS), which is widely used in the cosmetics industry. It is a reliable in vitro test that determines the eye irritation potentials of new products based on human tissue. Invitro International has become a leading company in the field of cell culture technology and is now known worldwide for its high-quality products and services. The company takes pride in offering its customers safe, effective, and environmentally friendly test systems and is committed to continuing to develop innovative solutions to meet the industry's requirements. Invitro International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Invitro International stock

FCF Conversion Rate (FCF/EBITDA) of Invitro International is -7.12 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Invitro International changed from 92.40 % to -7.12 %, representing a -107.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Invitro International since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Invitro International with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Invitro International

All Key Metrics — Invitro International